DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
| Revenue (Most Recent Fiscal Year) | $3.62B |
| Net Income (Most Recent Fiscal Year) | $541.50M |
| PE Ratio (Current Year Earnings Estimate) | 76.31 |
| PE Ratio (Trailing 12 Months) | 88.94 |
| PEG Ratio (Long Term Growth Estimate) | 2.31 |
| Price to Sales Ratio (Trailing 12 Months) | 14.29 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 25.08 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 64.90 |
| Pre-Tax Margin (Trailing 12 Months) | 19.61% |
| Net Margin (Trailing 12 Months) | 14.95% |
| Return on Equity (Trailing 12 Months) | 28.31% |
| Return on Assets (Trailing 12 Months) | 9.74% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.84 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.48 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 1.18 |
| Inventory Turnover (Trailing 12 Months) | 2.89 |
| Book Value per Share (Most Recent Fiscal Quarter) | $5.35 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.50 |
| Earnings per Share (Most Recent Fiscal Year) | $1.52 |
| Diluted Earnings per Share (Trailing 12 Months) | $1.31 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 385.52M |
| Free Float | 383.93M |
| Market Capitalization | $51.77B |
| Average Volume (Last 20 Days) | 2.34M |
| Beta (Past 60 Months) | 1.20 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.41% |
| Percentage Held By Institutions (Latest 13F Reports) | 97.75% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |